SCHEMBL24130536

SCHEMBL24130536

N#CC(C#N)=NNc1ccc2[nH]c(=O)ccc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.54
▸ CYP3A4 P08684 3/20 0.54
▸ HIF1A Q16665 2/20 0.54
▸ CYP1A2 P05177 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ MAPT P10636 10/20 0.44
▸ MEN1 O00255 7/20 0.44
▸ KMT2A Q03164 7/20 0.44
▸ TDP1 Q9NUW8 5/20 0.44
▸ ALOX15 P16050 2/20 0.44
▸ TSHR P16473 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ CISD1 Q9NZ45 1/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.43
▸ MMP14 P50281 1/20 0.43
▸ CACNA1B Q00975 1/20 0.43
▸ APBA1 Q02410 1/20 0.43
▸ MCL1 Q07820 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26279799 0.81 CA12 (0.50) MAPTMEN1KMT2AF11CA12
SCHEMBL24130428 0.78 HPGD (0.46) ALDH1A1CYP3A4HIF1ACYP1A2CYP2C9
SCHEMBL24706332 0.78 ALDH1A1 (0.55) ALDH1A1CYP3A4HIF1ACYP1A2CYP2C9
SCHEMBL24706318 0.78 CYP3A4 (0.55) ALDH1A1CYP3A4HIF1ACYP1A2CYP2C9
SCHEMBL24130116 0.75 ALDH1A1 (0.48) ALDH1A1CYP3A4HIF1ACYP1A2CYP2C9
SCHEMBL922420 0.74 MAPT (0.57) ALDH1A1CYP3A4HIF1ACYP1A2CYP2C9
SCHEMBL24130479 0.74 CYP3A4 (0.47) ALDH1A1CYP3A4HIF1ACYP1A2CYP2C9
SCHEMBL922446 0.73 CYP3A4 (0.80) ALDH1A1CYP3A4HIF1ACYP1A2CYP2C9
SCHEMBL24130673 0.71 ALDH1A1 (0.50) ALDH1A1CYP3A4HIF1ACYP1A2CYP2C9
SCHEMBL28219215 0.71 CA12 (0.51) MAPTMEN1KMT2AF11CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-21 — — US disclosed
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-21 — — US disclosed
EP-4169905-A1 NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF Korea Institute of Science and Technology (KR) 2023-04-26 — — EP disclosed
WO-2021256899-A1 NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF 한국과학기술연구원 2021-12-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF CBR3, DBF4, DDT ALDH1A1 1343/4885CYP3A4 167/4885HIF1A 3330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback